Padam Kanta Dahal
Oncology — Central Queensland University, Australia
Padam Kanta Dahal
LeadR Profile
Oncology
Subspecialties: Public Health - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 34
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Title: Catastrophic Out-of-Pocket Healthcare Expenditures Among Cancer Patients Receiving Systemic and Radiation Therapy in Bangladesh. radiotherapy, financial stress, hospitals, private, neoplasms, income, therapeutics, health expenditures | J Cancer Policy | 2026 | 0 |
| Cancer Burden in Bangladesh: Insights From National Institute of Cancer Research & Hospital, 2014-2020. lymph nodes, breast neoplasms, respiratory system, neoplasms, lymph, breast, research | JCO Glob Oncol | 2026 | 0 |
| Economic value, affordability, and scale-up of adjuvant immunotherapies in lung cancer treatment: From cost-effectiveness decision to budget impact analysis. lung, neoplasms, drug therapy, immunotherapy, lung neoplasms, nivolumab, budgets, quality-adjusted life years, therapeutics, chemotherapy | J Cancer Policy | 2026 | 0 |
| Cost-Effectiveness of Adjuvant Immunotherapy in Cancer Treatments: A Systematic Review. cells, lung, pharmaceutical preparations, neoplasms, carcinoma, non-small-cell lung, immunotherapy, lung neoplasms, small cell lung carcinoma, quality-adjusted life years, therapeutics | JAMA Oncol | 2026 | 0 |
| Assessing inequalities in health utility scores among cancer patients undergoing systemic and radiation therapy. radiotherapy, neoplasms, outcome assessment, health care, therapeutics | Health Qual Life Outcomes | 2025 | 0 |
LeadR Networks
Main global connection map